Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.
J Clin Invest · 2017
Last updated 2026-05-28A study found that a GLP-1 drug called exendin-4 (Ex-4) increased the growth of insulin-producing cells in human pancreatic tissue from younger donors but not from adults. The effect in younger cells required a specific signaling pathway involving calcineurin/NFAT. Ex-4 also boosted insulin release in both younger and adult cells, showing that the age-related difference was in cell growth, not insulin function.
AI summary of the abstract below.
| Journal | J Clin Invest, 2017 |
|---|---|
| Citations | 123 |
| Relative citation ratio | 4.37 |
| NIH percentile | 91 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
Inadequate pancreatic β cell function underlies type 1 and type 2 diabetes mellitus. Strategies to expand functional cells have focused on discovering and controlling mechanisms that limit the proliferation of human β cells. Here, we developed an engraftment strategy to examine age-associated human islet cell replication competence and reveal mechanisms underlying age-dependent decline of β cell proliferation in human islets. We found that exendin-4 (Ex-4), an agonist of the glucagon-like peptide 1 receptor (GLP-1R), stimulates human β cell proliferation in juvenile but not adult islets. This age-dependent responsiveness does not reflect loss of GLP-1R signaling in adult islets, since Ex-4 treatment stimulated insulin secretion by both juvenile and adult human β cells. We show that the mitogenic effect of Ex-4 requires calcineurin/nuclear factor of activated T cells (NFAT) signaling. In juvenile islets, Ex-4 induced expression of calcineurin/NFAT signaling components as well as target genes for proliferation-promoting factors, including NFATC1, FOXM1, and CCNA1. By contrast, expression of these factors in adult islet β cells was not affected by Ex-4 exposure. These studies reveal age-dependent signaling mechanisms regulating human β cell proliferation, and identify elements that could be adapted for therapeutic expansion of human β cells.
Verbatim abstract via PubMed 28920919 ↗